Nephrotic syndrome with diffuse endocapillary proliferative glomerulonephritis digital illustration

Nephrotic syndrome with diffuse endocapillary proliferative glomerulonephritis Save


ICD-10 code: N04.4

Disease category: N04: Nephrotic syndrome

Nephrotic Syndrome with Diffuse Endocapillary Proliferative Glomerulonephritis: An Overview

Nephrotic syndrome with diffuse endocapillary proliferative glomerulonephritis (DEPGN) is a rare kidney disorder characterized by inflammation of the glomeruli, the tiny filters in the kidneys. This condition typically leads to nephrotic syndrome, a collection of symptoms including proteinuria (excessive protein in the urine), edema (swelling), hypoalbuminemia (low levels of albumin in the blood), and hyperlipidemia (elevated blood lipid levels).

DEPGN is a form of glomerulonephritis, which refers to the inflammation of the glomeruli. In this specific type, there is a proliferation of cells within the glomerular capillaries, leading to damage and dysfunction of the kidneys. Although the exact cause of DEPGN is unknown, it is believed to be an immune-mediated response triggered by various factors, such as infections, autoimmune diseases, or certain medications.

The clinical presentation of nephrotic syndrome with DEPGN can vary from person to person. Common symptoms include swelling, especially around the eyes, hands, feet, and abdomen, foamy or frothy urine, fatigue, and weight gain due to fluid retention. Laboratory tests often reveal high levels of protein in the urine and abnormal lipid profiles.

Diagnosing DEPGN requires a kidney biopsy, which involves removing a small piece of kidney tissue for microscopic examination. The biopsy helps confirm the presence of endocapillary proliferation and assess the severity of glomerular damage. Additional tests, such as blood tests and imaging studies, may be performed to identify underlying causes or associated complications.

While treatment options for nephrotic syndrome with DEPGN primarily focus on addressing the underlying cause and managing symptoms, it is important to consult a healthcare professional for proper guidance. Treatment may involve immunosuppressive medications, such as corticosteroids or other immunosuppressants, to reduce inflammation and control the immune response. Lifestyle modifications, including a low-sodium diet and fluid restriction, may also be recommended to manage edema and blood pressure.

  1. Summary
  2. Causes and Risk Factors
  3. Symptoms and Presentation
  4. Diagnosis
  5. Treatment Options

In conclusion, nephrotic syndrome with diffuse endocapillary proliferative glomerulonephritis is a complex kidney disorder characterized by inflammation and damage to the glomeruli. While treatment options aim to address the underlying cause and manage symptoms, it is crucial to consult a healthcare professional for accurate diagnosis and personalized treatment plans

Treatment of Nephrotic syndrome with diffuse endocapillary proliferative glomerulonephritis:

Treatment Options for Nephrotic Syndrome with Diffuse Endocapillary Proliferative Glomerulonephritis

Nephrotic syndrome with diffuse endocapillary proliferative glomerulonephritis is a rare kidney disorder characterized by inflammation and damage to the glomeruli, the tiny blood vessels in the kidneys. This condition often leads to proteinuria, edema, and high cholesterol levels. I...

To see full information about treatment please Sign up or Log in